Articles tagged with Cancer Patients
Advanced liver fibrosis worsens cancer-specific and overall survival in iCCA patients, regardless of surgical resection. Patients with advanced fibrosis are at increased risk of mortality across follow-up periods.
A study by the Mays Cancer Center at UT Health San Antonio found that bladder cancer is more advanced and deadly in South Texas residents than in many parts of the country. The disease disproportionately affects Latinos and women, with worse survival rates regardless of geographic location.
A new study reveals that one-third of cancer survivors experienced disruptions in healthcare treatments and financial worries due to the pandemic. Cancer survivors reported feeling isolated and concerned about their health, with some unable to bring a companion to in-person appointments.
A machine learning-based model predicts the probability of lung cancer among patients with multiple pulmonary nodules, achieving high accuracy in validation cohorts. The PKU-M model also surpasses prior logistic regression-based models and a previously established AI tool in diagnosis.
A new study by Yale Cancer Center found sex hormones and insulin growth factors are associated with recurrence risk of endometrial cancer. The findings suggest a possible new approach in the prevention and treatment of endometrial cancer recurrence, which is currently being evaluated in a multi-center trial.
Patients with cancer and multiple physical comorbidities are more likely to experience high psychological distress and consult mental healthcare professionals. These findings highlight the importance of considering physical conditions when addressing mental health in cancer patients.
A phase III randomized study found that lenvatinib plus pembrolizumab significantly prolonged survival in patients with advanced kidney cancer. Treatment combinations showed improved progression-free and overall survival rates compared to sunitinib.
Researchers identified a protein, netrin-4, associated with tumour and vessel softness, which determines cancer spread even before cancer develops in several types. Removing or increasing this protein reduces cancer spread.
A new study shows that liquid biopsies can detect lingering disease in patients with oligometastatic colorectal cancer, guiding treatment decisions. The biopsies identify patients who may benefit from immune therapies or targeted treatments based on mutations detected in blood samples.
A collaboration between George Mason University and Rutgers Cancer Institute aims to validate a new test for measuring HER2 biomarkers, which can predict patient response to treatment. The test uses advanced technology to analyze tissue samples and identify specific therapies for individual patients.
A urine test has been found to be extremely accurate at detecting aggressive prostate cancer with few false negatives. The test avoids unnecessary biopsies for patients with slow-growing or no cancer, reducing costs and invasive procedures.
Researchers found that activating STING molecule reduced GVHD severity and mortality rates in a mouse model. The study suggests that a STING-activating drug might protect bone marrow transplant recipients from GVHD.
A single strain of Bacteroides fragilis significantly reduced graft-versus-host disease by protecting gut integrity, according to a proof-of-concept study. The bacteria increased overall gut microbial diversity and reduced donor T cell proliferation, which triggers GVHD.
Inherited genetic variation plays a role in who responds best to checkpoint inhibitors, which release the immune system's brakes. The study identified 22 regions or genes with significant effects on the immune system's response to cancer.
Researchers used a mouse cachexia model to investigate myocardial damage in tumor-bearing mice, finding suppressed oxidative phosphorylation and glycolysis. The study validates the model for studying cancer-derived myocardial impairment, revealing various changes associated with cancer cachexia.
Researchers found that vitamin D supplementation could reduce cancer mortality rates by around 13 percent, resulting in potential savings of €254 million per year. The study suggests that widespread vitamin D supplementation among Germans over 50 could prevent up to 30,000 cancer deaths annually and gain more than 300,000 years of life.
A nationwide study aims to better understand the intersection of COVID-19 and cancer, examining long-term outcomes and treatment protocols. The research hopes to identify key factors that make certain patients more prone to severe COVID-19 infections.
Researchers found fecal transplant increased immune cell activation and decreased immunosuppression in responders, suggesting a link between gut microbiome changes and treatment effectiveness. The study's results raise hope for microbiome-based therapies of cancers.
Scientists at Case Western Reserve University have discovered biomarkers using AI analysis of simple tissue scans to predict which lung cancer patients will be harmed by immunotherapy. This new work builds on previous research that used AI and machine learning to identify patients who will benefit from the treatment.
The European Union has funded a project to develop diagnostic tools and combination treatments for ovarian cancer using AI. The research aims to identify patients whose cancer is not responding to current treatments and discover effective, personalized therapies.
A new study suggests that fecal microbiota transplants can help patients with advanced melanoma respond to immunotherapy drugs. After receiving a transplant, six out of 15 patients showed improved cancer stability or tumor reduction.
The BeamSite Cherenkov imaging camera system captures real-time images of the beam directly on the patient, allowing radiation oncologists to verify accuracy of dose and beam delivery. This technology has improved treatment quality, precision, and patient safety during radiation therapy.
A study by Mayo Clinic researchers found that certain biomarkers can help diagnose acute kidney inflammation in cancer patients treated with immune checkpoint inhibitors. These biomarkers, such as serum creatinine and C-reactive protein, may aid in distinguishing treatment-associated kidney injury from other causes.
Researchers found that healthcare professionals have knowledge gaps when caring for LGBTQ2SPIA+ cancer patients, affecting their ability to provide emotional support and tailored care. The study concludes that patient-centered care requires specific resources and education for radiation therapists.
A new ultrasound technique called MRI-guided focused ultrasound ablation (MRgFUS) effectively treats intermediate-risk prostate cancer with minimal side effects. Treatment was successfully completed in all 44 men, with no major adverse events and 93% disease-free at the treatment site.
A new 523-gene panel has been developed to diagnose and treat acute myeloid leukemia (AML), identifying more genetic mutations and potential treatment targets. The panel has shown high sensitivity and specificity in detecting AML and has the potential to improve patient outcomes.
A novel metabolic gatekeeper mechanism for leukemia has been discovered by Yale researchers, highlighting the importance of glucose and energy supply in leukemic transformation. High expression levels of PON2 enable glucose uptake activity in B-cell acute lymphoblastic leukemia cells, leading to a more aggressive course of disease.
Research found that black patients diagnosed with non-small cell lung cancer are more likely to be diagnosed at an advanced stage and have lower chances of receiving surgery. Additionally, they experience significantly reduced cancer-specific survival rates compared to their white counterparts.
A new study reveals that older minority cancer patients with poor social determinants experience negative surgical outcomes, including higher complication rates and mortality. Researchers suggest integrating vulnerability assessments into national standard of care models to improve outcomes.
A study found that older cancer patients residing in areas with high social vulnerability are less likely to achieve textbook outcomes following surgery. The research used the Social Vulnerability Index (SVI) to analyze the impact of socioeconomic challenges on health outcomes.
Researchers found a high prevalence of cardiovascular conditions in male breast cancer patients, including overweight, high blood pressure, and high cholesterol. The study highlights the need for cardiologists and cardio-oncologists to be involved in treatment due to common risk factors and potential cardiotoxic effects.
Research found cancer patients in low-income countries are up to four times more likely to die following surgery, with less post-operative care infrastructure and oncology services. Patients from upper middle-income countries were two times as likely to die compared to high-income countries.
The COVID-19 pandemic saw a decrease in radiotherapy treatment courses, particularly among older patients. The new study reveals that the English NHS adapted its services quickly to protect patients, with some types of cancer seeing increased use of radiotherapy.
A phase 1b/2 trial shows that combining eprenetapopt with azacitidine improves overall response rate to 71% in TP53 mutant MDS and AML patients. The median overall survival is 10.8 months, with improved outcomes for those who responded to treatment.
The global demand for cancer surgery is projected to increase by 52% between 2018 and 2040, with the largest relative increase in low-income countries. Improving care systems worldwide is crucial to reduce mortality rates from complications.
A study of nearly 16,000 patients across 82 countries found that low-and lower-middle-income countries had significantly higher mortality rates following surgery due to inadequate facilities and care plans. Investing in proper recovery spaces, trained staff, and critical care facilities can greatly improve surgical outcomes.
Researchers have developed a new integrated genetic/epigenetic DNA-sequencing protocol called MultiMMR that can identify mismatch repair (MMR) deficiency in a single test. This alternative to complex testing workflows determines causes of MMR deficiency often missed by current clinical tests.
Researchers develop bioengineered microscale organotypic models (BMOMs) to address cancer treatment limitations. BMOMs can be integrated with microscopes and sensors to monitor biological processes in high resolution, reducing the need for animal models.
A new study from Penn Medicine reveals that patients with inactive cancer and not currently undergoing treatments are significantly more likely to experience severe COVID-19 illness. The research highlights the importance of COVID-19 mitigation measures, such as social distancing and mask-wearing, and vaccinations for all patients.
Researchers at Johns Hopkins Medicine have developed a new experimental therapy that prevents premature birth using nanosized particles of drugs. The treatment decreases contractions in uterine muscles and could be a clinical option for preventing preterm labor.
Dartmouth researchers have developed a method to convert standard linear accelerators to deliver ultra-high-dose rate radiation therapy beams, known as FLASH. The beams have been shown to protect normal tissues from excess damage while maintaining the same treatment effect on tumor tissues.
The NRG Oncology phase II clinical trial determined that the combination of total neoadjuvant therapy with pembrolizumab and chemoradiotherapy is safe for patients with locally-advanced rectal cancer (LARC). However, it may not offer any statistically significant improvement in downstaging of the cancer at the time of surgery.
A study of 1,347 pediatric tumors found NTRK fusions in 29 cases, detected in 13% of papillary thyroid carcinomas and 1.9% of CNS tumors, offering new insights into prioritizing screening for targeted treatment with TRK inhibitors.
Researchers found that mice with different types of T cells responded differently to tumors, with some rejecting them and others succumbing to development. The study aims to develop more effective personalized immunotherapy for cancer patients by understanding the role of T cells in immune response variation.
A new study by Johns Hopkins Medicine found that various oral sex behaviors may increase the risk of oral HPV infection and head and neck cancer. Behaviors such as having multiple partners, early age of sexual initiation, and higher 'intensity' of oral sex were associated with a higher risk of the disease.
Research at Charité - Universitätsmedizin Berlin found that patients' immune systems before chemotherapy determine treatment success in bladder cancer. High levels of CXCL11 and CXCR3alt receptors indicate a strong immune response, leading to increased survival rates.
The COVID-19 pandemic significantly affected cancer screening test utilization and subsequent cancer diagnoses in the largest US healthcare system. Researchers analyzed data to understand the impact of the pandemic on cancer care.
A UK trial using computer algorithms shows that early-stage cancer patients can better manage their symptoms and improve their physical wellbeing through remote monitoring. The eRAPID system provided instant advice on symptom management, leading to a cost-effective solution with better patient outcomes.
A new study found that a Mediterranean-style diet may help slow the progression of prostate cancer in men who are not seeking immediate treatment. Men with localized prostate cancer who followed a more plant-based diet had a lower risk of cancer growth or advancement, regardless of their age, PSA levels, or tumor volume.
Virtual care during COVID-19 accelerated at Princess Margaret Cancer Centre, showing high patient and physician satisfaction. The study found significant cost savings for patients and comparable or better quality of care.
A new study published in JAMA Network Open shows that deep learning can help predict occult peritoneal metastasis in stomach cancer. The researchers developed a deep learning model called Peritoneal Metastasis Network (PMetNet) to predict clinically occult peritoneal metastasis using preoperative computed tomography images.
Researchers developed a gene expression signature that robustly predicts patient survival in patients with peritoneal carcinomatosis, a form of metastatic gastric cancer. The signature is associated with tumor cell populations and lineage compositions, offering potential for tailored treatment strategies.
A new study published in Cancer suggests that inflammation from ADT is linked to higher levels of fatigue in prostate cancer patients. The researchers found an increase in the inflammation marker IL-6 in this group, which may contribute to symptoms.
The COVID-19 pandemic significantly challenges cancer prevention and control in Africa, diverting resources away from cancer patients. However, this crisis also creates opportunities for innovation and improved access to cancer care.
Researchers have classified angiosarcomas into three subtypes based on genomic and immune profiles, enabling personalized treatment approaches. The study suggests that checkpoint immunotherapy can be effective for clusters one and three, while tumour-promoting genes in cluster two may be explored as potential targets.
Researchers have identified seven DNA fingerprints that define cancer risk, including a protective germline pattern and six that present a higher risk. The discovery refines the long-held view that lifestyle factors contribute to cancer risk and sheds light on the role of genetics in cancer development.
Researchers discovered that abatacept reduced severity of myocarditis in genetic mouse model and human patients. The study provides a potential new treatment option for patients with immune-related side effects from immunotherapies.
A landmark study by researchers from the SWOG Cancer Research Network has found that 2.8 percent of cancer patients develop osteonecrosis of the jaw within three years of starting zoledronic acid treatment. The study, which followed 3,491 patients over three years, also identified risk factors and impact on quality of life.
The COVID-19 pandemic has significantly affected cancer treatment outcomes, with social distancing efforts potentially leading to better or worse results for patients. The study explores the implications of these measures on health behaviors and their consequences for cancer control.
The FDA has approved pembrolizumab, a new immunotherapy drug, as the first-line treatment for patients with advanced colorectal cancer. This approval was made possible by early results from a phase III clinical trial funded by Stand Up To Cancer (SU2C) research.